AbbVie Secures EU Approval for RINVOQ to Treat Active Polyarticular Juvenile Idiopathic Arthritis in Children #None #AbbVie #RINVOQ #Juvenile_Arthritis
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialAbbVie Secures EU Approval for RINVOQ to Treat Active Polyarticular Juvenile Idiopathic Arthritis in Children #None #AbbVie #RINVOQ #Juvenile_Arthritis